PROVIDER PROFILE · NPI 1477788172

Biswashree ChaudhuryM.D.

Internal MedicineDuluth, GAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,045

Unique beneficiaries

—

Total services

1,351

Distinct HCPCS

Medicare payment

$116K

Peer benchmark

Total Medicare services vs. 2,751 Internal Medicine providers in GA — above median (cohort median 670).

PRESCRIBING · PART D · 2024

Total Rx claims

7,664

Beneficiaries

—

Total drug cost

$367K

Distinct drugs

109

Brand share

15.1%

Top prescribed drugs

Atorvastatin Calcium901 claims

Amlodipine Besylate515 claims

Rosuvastatin Calcium427 claims

Lisinopril317 claims

Metformin Hcl305 claims

QUALITY · MIPS · 2024

Final MIPS score

94.5

Quality

80.6

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.82%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Biswashree Chaudhury's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 4 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Robert Huber Internal Medicine · Duluth, GA	18	41
Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL	12	16

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Tucker, GA	135	318
NORTHSIDE HOSPITAL, INC.	35	84
Robert Huber Internal Medicine · Duluth, GA	19	38
NORTHSIDE HOSPITAL, INC.	15	25

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history